semaglutide and psoriatic arthritis GLP-1 Agonists Psoriasis: A Potential Novel Therapeutic Approach GLP-1 Drugs Tackle Both Skin

Semaglutide typically begins reducing appetite within three to five days of your first injection, though meaningful weight loss usually appears after two to four weeks of consistent dosing

This Canadian development could have broader implications across North America, potentially influencing how metabolic health treatments are delivered and priced in the future

New research suggests GLP-1 medications may influence osteoarthritis beyond weight loss

GLP-1 receptor agonist

Explore UK prescribing guidance and efficacy data for tirzepatide.

Trulicity is a prescription medication used to treat type 2 diabetes. It is in the class of drugs called GLP-1 receptor agonists and works by stimulating the release of insulin and decreasing the production of sugar by the liver. The pre-filled pens come in a pack of 4 and contain a solution of dulaglutide, the active ingredient, in a concentration of 1.5 mg per 0.5 mL. These pens are used to inject Trulicity subcutaneously (under the skin) once a week and are intended for single-use only. They are convenient and easy to use, allowing patients to self-administer their medication at home